Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1320
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04115059 | Dasatinib In Waldenström Macroglobulinemia | ||
| NCT00181688 | Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian Cancer | ||
| NCT00116142 | Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer | ||
| NCT02028988 | Enzalutamide + External Beam Rt For Prostate | ||
| NCT05643027 | A Novel Intervention for Patients With Cancer | ||
| NCT06802146 | Early Intervention in High Risk CCUS | ||
| NCT01323920 | Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors | ||
| NCT02823262 | A Breast Cancer Treatment Decision Aid for Women Aged 70 and Older | ||
| NCT00577642 | Bone Marker Assessment of Multiple Myeloma Patients Treated With Aminobisphosphonates | ||
| NCT03051659 | A Randomized Phase II Study Of Eribulin Mesylate With or Without Pembrolizumab For Metastatic Hormone Receptor Positive Breast Cancer | ||
| NCT03429803 | DAY101 In Gliomas and Other Tumors | ||
| NCT02926911 | Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS | ||
| NCT02390414 | The Myelodysplasia Transplantation-Associated Outcomes (MDS-TAO) Study | ||
| NCT00361621 | Ph II CHOP+Velcade in Mediastinal LBCL | ||
| NCT00148707 | Study of Xyotax (CT-2103) in Patients With Metastatic Breast Cancer | ||
| NCT07227584 | ALL Backbone in AYAs | ||
| NCT06414434 | BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma | ||
| NCT06543511 | MyeloGen: Germline Testing for Predisposition to Myeloid Malignancies | ||
| NCT00330252 | Weekly Subcutaneous Alemtuzumab and Rituximab for Relapsed CLL | ||
| NCT03637543 | Nivolumab in Patients With High-Risk Biochemically Recurrent Prostate Cancer | ||
| NCT04908852 | Feasibility Pilot Exploring Variability in Biomarkers and PROs in AML | ||
| NCT04323774 | Intervention For Adolescents and Young Adults (AYAs) With Cancer Risk Syndromes | ||
| NCT06317220 | Vedolizumab for the Treatment of Collagenous Gastritis | ||
| NCT02438358 | Feasibility Study of Intraoperative Imaging in Breast Cancer | ||
| NCT02666378 | Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer | ||
| NCT00459043 | Docetaxel in Combination With Zactima (ZD6474) in Patients With Locally Advanced Squamous Cell Carcinoma of the the Head and Neck | ||
| NCT02582697 | Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours | ||
| NCT05383196 | Onvansertib + Paclitaxel In TNBC | ||
| NCT02774850 | Home Away From Home - Medical Outcomes | ||
| NCT04724018 | Sacituzumab Govitecan Plus EV in Metastatic UC | ||
| NCT03636503 | Rituximab + Immunotherapy in Follicular Lymphoma | ||
| NCT01294670 | Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors | ||
| NCT00819546 | RAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDS | ||
| NCT06677190 | Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin | ||
| NCT07358260 | B7-H3.CD28Z.CART in Solid Tumors | ||
| NCT02514824 | MLN0128 in Recurrent/Metastatic Merkel Cell Carcinoma | ||
| NCT00139191 | Study Evaluating the Correlation Between C-11 Acetate Uptake and Retention as Measured by PET and FAS in Prostate Cancer | ||
| NCT01024946 | Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity | ||
| NCT05524025 | The SPOT-HPV Study | ||
| NCT02248662 | Impact of Radiation Therapy on Breast Conservation in DCIS | ||
| NCT01829217 | Sunitinib in Never-Smokers With Lung Adenocarcinoma | ||
| NCT07147023 | Better Real-time Information on Documentation of Goals of Care for Engagement in Serious Illness Communication | ||
| NCT04134559 | Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma | ||
| NCT00006106 | ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer | ||
| NCT03131206 | A Study of Alectinib in RET-rearranged Non-small Cell Lung Cancer or RET-mutated Thyroid Cancer | ||
| NCT00495755 | Campath in Chronic GVHD | ||
| NCT01629615 | A Trial of BKM120 (a PI3K Inhibitor) in Patients With Triple Negative Metastatic Breast Cancer | ||
| NCT00431210 | Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma | ||
| NCT01177527 | Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders | ||
| NCT06563596 | Epco, Zanu, Ritux for R/R FL or MZL |
